Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ABL Inc
ABL Inc
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Advanced Biological Laboratories reaches milestone for COVID-19 assay
ABL has received CE-IVD Registration for its UltraGene Combo2Screen SARS-CoV-2 Assay
Containment
ABL acquires former Accinov GMP manufacturing plant
The US biotech CDMO now operates a 6,500sqm facility in Lyon equipped with grade B and C cleanrooms and self-contained labs
Manufacturing
Sartorius supports ABL Europe to expand viral vector GMP capacity
A global technology player in the biopharma industry supports a supplier of viral vector manufacturing services to successfully complete a capacity expansion
Finance
Transgene sells biopharmaceutical manufacturing facility to ABL Europe
Also signs a three-year deal with ABL Europe to produce clinical lots of immunotherapies under development for cancer and infectious diseases
Subscribe now